Skip to main content
. Author manuscript; available in PMC: 2018 Feb 19.
Published in final edited form as: Oncogene. 2015 Oct 12;35(23):3071–3078. doi: 10.1038/onc.2015.371

Figure 6.

Figure 6

Dominant negative activity of ZBTB7A zinc finger mutants. (a–c) Luciferase assay was performed using GLUT3 promoter-driving luciferase reporter. Increasing dose of R399L (a), R402H (b) and H404R (c) ZBTB7A were combined with or without wild-type ZBTB7A. (d–f) Luciferase assay was performed using PFKP promoter-driving luciferase reporter. Increasing dose of R399L (d), R402H (e) and H404R (f) ZBTB7A was combined with or without wild-type ZBTB7A. Average values of three independent experiments are shown, error bars indicate ± s.d. * indicates P < 0.05.